Jump to content

KSC-12-192: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Reph-415 (talk | contribs)
No edit summary
Reph-415 (talk | contribs)
No edit summary
Line 29: Line 29:
Compared with most of the known KOR G-protein biased agonists, KSC-12-192 and its parent compound [[ML138]] have no [[Stereoisomerism|stereoisomers]].
Compared with most of the known KOR G-protein biased agonists, KSC-12-192 and its parent compound [[ML138]] have no [[Stereoisomerism|stereoisomers]].


<small>
{| class="wikitable" style="background-color:white;text-align:center;"
{| class="wikitable" style="background-color:white;text-align:center;"
|-
|-
| || ||
| || colspan="3" | Name(s)
| style="width: 3em;" | X
| style="width: 3em;" | X
| style="width: 3em;" | R<sub>1</sub>
| style="width: 3em;" | R<sub>1</sub>
Line 37: Line 38:
| style="width: 3em;" | R<sub>3</sub>
| style="width: 3em;" | R<sub>3</sub>
|-
|-
| rowspan="6" | [[File:KSC-12-192 common scaffold.png|frameless]] || '''KSC-12-192''' || probe 1.1
| rowspan="6" | [[File:KSC-12-192 common scaffold.png|frameless]] || || '''KSC-12-192'''|| probe 1.1
| O || H || CH<sub>3</sub> || CF<sub>3</sub>
| O || H || CH<sub>3</sub> || CF<sub>3</sub>
|-
|-
| '''ML138''' (KSC-5-240) || probe 1
| '''ML138''' || KSC-5-240 || probe 1
| O || H || Cl || Cl
| O || H || Cl || Cl
|-
|-
| KUC103903N (KSC-5-247G) ||
| KUC103903N || KSC-5-247G ||
| S || H || Cl || Cl
| S || H || Cl || Cl
|-
|-
| KUC105892N (KSC-12-193) || probe 1.3
| KUC105892N || KSC-12-193 || probe 1.3
| S || H || CH<sub>3</sub> || CF<sub>3</sub>
| S || H || CH<sub>3</sub> || CF<sub>3</sub>
|-
|-
| KUC105904N (KSC-12-238-B5) || probe 1.4
| KUC105904N || KSC-12-238-B5 || probe 1.4
| O || CH<sub>3</sub> || CH<sub>3</sub> || CF<sub>3</sub>
| O || CH<sub>3</sub> || CH<sub>3</sub> || CF<sub>3</sub>
|-
|-
| KUC105903N (KSC-12-238-B4) ||
| KUC105903N || KSC-12-238-B4 ||
| O || CH<sub>3</sub> || Cl || Cl
| O || CH<sub>3</sub> || Cl || Cl
|}
|}
</small>


== References ==
== References ==

Revision as of 09:55, 21 March 2023

This sandbox is in the article namespace. Either move this page into your userspace, or remove the {{User sandbox}} template.

KSC-12-192
Clinical data
Other names"probe 1.1"
ATC code
  • None
Identifiers
  • 2-[4-(furan-2-ylmethyl)-5-[[4-methyl-3-(trifluoromethyl)phenyl]methylsulfanyl]-1,2,4-triazol-3-yl]pyridine
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC21H17F3N4OS
Molar mass430.45 g·mol−1
3D model (JSmol)
  • CC1=C(C=C(C=C1)CSC2=NN=C(N2CC3=CC=CO3)C4=CC=CC=N4)C(F)(F)F
  • InChI=1S/C21H17F3N4OS/c1-14-7-8-15(11-17(14)21(22,23)24)13-30-20-27-26-19(18-6-2-3-9-25-18)28(20)12-16-5-4-10-29-16/h2-11H,12-13H2,1H3
  • Key:OQJGZGAYSCWFCK-UHFFFAOYSA-N

KSC-12-192 is a drug that is used in scientific research to study the κ-opioid receptor, where it acts as a biased agonist.[1]

KSC-12-192 preferentially activates G-protein coupling over β-arrestin 2 recruitment in vitro, an intrinsic activity shared with many other KOR ligands developed to separate KOR-mediated analgesia from accompanying dysphoria.

Compared with most of the known KOR G-protein biased agonists, KSC-12-192 and its parent compound ML138 have no stereoisomers.

Name(s) X R1 R2 R3
KSC-12-192 probe 1.1 O H CH3 CF3
ML138 KSC-5-240 probe 1 O H Cl Cl
KUC103903N KSC-5-247G S H Cl Cl
KUC105892N KSC-12-193 probe 1.3 S H CH3 CF3
KUC105904N KSC-12-238-B5 probe 1.4 O CH3 CH3 CF3
KUC105903N KSC-12-238-B4 O CH3 Cl Cl

References

  1. ^ Zhou, Lei; Lovell, Kimberly M.; Frankowski, Kevin J.; Slauson, Stephen R.; Phillips, Angela M.; Streicher, John M.; Stahl, Edward; Schmid, Cullen L.; Hodder, Peter; Madoux, Franck; Cameron, Michael D.; Prisinzano, Thomas E.; Aubé, Jeffrey; Bohn, Laura M. (2013-12-20). "Development of functionally selective, small molecule agonists at kappa opioid receptors". The Journal of Biological Chemistry. 288 (51): 36703–36716. doi:10.1074/jbc.M113.504381. ISSN 1083-351X. PMC 3868780. PMID 24187130.{{cite journal}}: CS1 maint: unflagged free DOI (link)